Search
Showing results for "1"
Research
Dendritic cells and multiple sclerosis: Disease, tolerance and therapyMultiple sclerosis (MS) is a devastating neurological disease that predominantly affects young adults resulting in severe personal and economic impact.
As WA's first research collaboration dedicated to mental health, we work across The Kids Research Institute Australia and beyond to do the research that the community wants to see happen.
News & Events
Embrace research presented at SMHR conferenceAssociate Professor Bep Uink and Head of Kulunga Aboriginal Unit Cheryl Bridge watched on by Associate Professor Yael Perry at the SMHR conference.
Discover the impact of our achievements in the "real world".
News & Events
Celebrating 35 years of impact at The Kids Research Institute AustraliaCoinciding with the Institute’s 35th year of research to improve the health and wellbeing of children and families, the 2025 Impact Report celebrates research which has been translated into policy or practice, and which has led to a paradigm shift in the way we respond to childhood health and wellbeing.
Research
Amped Out: An Energy Drink StudyThe Kids Research Institute Australia is conducting a research study to evaluate a 4-month trial ban on the sale of energy drinks to children in all retail stores in Bridgetown.
Research
The course and prognostic capability of motor difficulties in infants showing early signs of autismDelays within the motor domain are often overlooked as an early surveillance marker for autism. The present study evaluated motor difficulties and its potential as an early predictive marker for later autism likelihood in a cohort of infants showing early behavioral signs of autism aged 9-14 months. The motor domain was evaluated using the motor subscales of the Mullen Scales of Early Learning at baseline, and at a 6-month follow-up.
Research
A flexible computational pipeline for research analyses of unsolved clinical exome casesExome sequencing has enabled molecular diagnoses for rare disease patients but often with initial diagnostic rates of ~25-30%. Here we develop a robust computational pipeline to rank variants for reassessment of unsolved rare disease patients. A comprehensive web-based patient report is generated in which all deleterious variants can be filtered by gene, variant characteristics, OMIM disease and Phenolyzer scores, and all are annotated with an ACMG classification and links to ClinVar.
Research
Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in AustraliaOur population-based cohort study demonstrates that >90% coverage in the first year of a universal 3 + 0 PCV program provided high population-level protection
Research
A randomised controlled trial of an iPad-based application to complement early behavioural intervention in Autism Spectrum DisorderTechnology-based interventions may provide a relatively low-cost addition to existing therapist-delivered interventions for children with ASD